Though MetLife has lagged behind the financial sector over the past year, Wall Street analysts maintain a moderately optimistic outlook on its prospects.
Aflac has trailed the broader Nasdaq Composite over the past year, and analysts are adopting a cautious stance on its outlook.
1 Large-Cap Stock on Our Buy List and 2 We Ignore
COLUMBUS, Ga. , Nov. 25, 2025 /PRNewswire/ -- Looking for a holiday gift that warms hearts and makes a real difference? Aflac's new children's book, "Beyond Words," does just that. This imaginative...
Designed to help children express empathy for those with health challenges, "Beyond Words" represents Aflac's newest expression of care with 100% of net proceeds benefiting the Aflac Childhood Cancer...
COLUMBUS, Ga. , Nov. 11, 2025 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) today announced that its Board of Directors has declared the first quarter dividend of $0.61 per share, payable on March...
As Aflac has underperformed the S&P 500 over the past year, Wall Street analysts maintain a cautious outlook about the stock’s prospects.
3 S&P 500 Stocks We Think Twice About
Aflac (NYSE:AFL) Delivers Impressive Q3